Clinical Trial

An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 24, 2026 (before its estimated April 6, 2026 completion). Its status may not reflect the trial's current state.
Summary
This clinical research study is being conducted to evaluate gut and digestive health before and after the use of a dietary supplement system over an eight-week period. Gut and digestive health play an important role in overall health, including digestion, nutrient absorption, immune function, and metabolic balance. Changes in gut microbiota, inflammation, and intestinal barrier function may contribute to digestive symptoms such as bloating, discomfort, altered bowel habits, and reduced well-being. In this study, adult men and women with self-reported gastrointestinal symptoms will consume a dietary supplement system daily for eight weeks. The study will measure changes in gut and digestive health using objective stool-based laboratory biomarkers and validated symptom questionnaires. Stool samples will be collected at baseline and at the end of the study to evaluate markers related to microbial diversity, inflammation, immune activity, digestive function, and intestinal barrier integrity. Participants will also complete questionnaires throughout the study to assess gastrointestinal symptoms and subjective digestive health and well-being. The study will also monitor the safety and tolerability of the dietary supplement system during the study period.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-12.
Trial Details
NCT Number NCT07421596
Lead Sponsor SF Research Institute, Inc.
Collaborators: Life Vantage
Conditions Gastrointestinal Symptoms, Digestive Health, Gut Health
Enrollment 50 participants
Start Date 2026-02-05
Primary Completion 2026-04-06 (estimated)
Study Completion 2026-04-21 (estimated)
Updated on ClinicalTrials.gov 2026-02-24